HANGZHOU, China, Oct. 31, 2022 /PRNewswire/ -- Broncus is pleased to denote that connected October 28, 2022, the Company's innovative merchandise successful the tract of drug-device combination, "Mist FountainTM" (the "Product" oregon "Nebulizing Micro-Catheter"), a disposable nebulizing micro-catheter for endoscope, has been officially approved for selling by Zhejiang Medical Products Administration. Currently, the Product is the lone nebulizing micro-catheter merchandise connected the marketplace which is approved and besides protected by aggregate patents successful China. Its exertion spans crossed aggregate indications and tin beryllium compatible with a assortment of drugs, broadening the exertion of drug-device operation successful the tract of lung illness treatment.
The Product is utilized successful conjunction with an endoscope to accurately scope the lesion nether the guidance of a navigation system, and is utilized for lavage and spraying of liquid medicine oregon with a radiocontrast agent. The patented microfluidic spot astatine the extremity of the Nebulizing Micro-catheter, with high-pressure infusion, tin trim the particle size of the cause to mist particles of 20 micrometers (μm), and the cause tin beryllium successful nonstop interaction with section lesions. The cause organisation tin beryllium much azygous and the section cause attraction tin beryllium importantly increased, thereby straight enhancing the attraction effect. The catheter itself is made of harmless materials with precocious cause compatibility and tin beryllium utilized to accommodate to a assortment of drugs. Its blunt-rounded front-end plan allows doctors to smoothly descent the Product successful and support the bronchial partition during operation, reducing the hazard of insubstantial damage.
The Company has been researching interventional pulmonary devices for years, and the Nebulizing Micro-catheter is the archetypal accomplishment of the Company successful the tract of drug-device combination. In the future, the Company volition cooperate with objective experts and biopharmaceutical enterprises to promote, amongst others, the imaginable exertion of the Nebulizing Micro-catheter successful the anesthesia of bronchoscopy surgery, tuberculosis treatment, targeted cause transportation for oncology. In addition, the Company volition proceed to research imaginable usage scenarios of the Product to screen a wider scope of lung illness treatments successful bid to consolidate starring advantages of the Company successful the tract of precision interventional diagnosis and attraction of pulmonary diseases.
SOURCE Broncus Holding Corporation
/cdn.vox-cdn.com/uploads/chorus_asset/file/24020034/226270_iPHONE_14_PHO_akrales_0595.jpg)
English (US)